Extracellular Vesicles as Novel Drug-Delivery Systems through Intracellular Communications

Membranes (Basel). 2022 May 25;12(6):550. doi: 10.3390/membranes12060550.

Abstract

Since it has been reported that extracellular vesicles (EVs) carry cargo using cell-to-cell comminication according to various in vivo situations, they are exprected to be applied as new drug-delivery systems (DDSs). In addition, non-coding RNAs, such as microRNAs (miRNAs), have attracted much attention as potential biomarkers in the encapsulated extracellular-vesicle (EV) form. EVs are bilayer-based lipids with heterogeneous populations of varying sizes and compositions. The EV-mediated transport of contents, which includes proteins, lipids, and nucleic acids, has attracted attention as a DDS through intracellular communication. Many reports have been made on the development of methods for introducing molecules into EVs and efficient methods for introducing them into target vesicles. In this review, we outline the possible molecular mechanisms by which miRNAs in exosomes participate in the post-transcriptional regulation of signaling pathways via cell-cell communication as novel DDSs, especially small EVs.

Keywords: adeno-associated virus; extracellular vesicles; intracellular communication; membrane vesicle production; non-coding RNAs.

Publication types

  • Review